Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06785636 |
| Title | Open-Label Study of Pocenbrodib and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 (P300) |
| Acronym | P300 |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Pathos AI, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Nebraska Cancer Specialists | RECRUITING | Omaha | Nebraska | 68130 | United States | Details |
| Oncology Consultants | RECRUITING | Houston | Texas | 77030 | United States | Details |
| NEXT Oncology - Virginia | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |